Agilent “Dialogues in CDx” Podcast Series
Agilent “Dialogues in CDx” Podcast Series
Podcast Description
Tune into candid conversations among professionals in companion diagnostics, an important field in the world of precision medicine. Blending expertise with real-world experience across multiple disciplines, this series aims to illuminate the challenges, approaches, and latest perspectives in companion diagnostics through thoughtful and educational dialogue.
Podcast Insights
Content Themes
The podcast focuses on companion diagnostics in precision medicine, with specific episodes addressing topics such as the complexity of PD-L1 scoring algorithms, the PD-L1 testing journey, and collaborative approaches between pathologists and oncologists. Examples include discussions on diagnostic cutoffs and the importance of efficient testing workflows.
Tune into candid conversations among professionals in companion diagnostics, an important field in the world of precision medicine. Blending expertise with real-world experience across multiple disciplines, this series aims to illuminate the challenges, approaches, and latest perspectives in companion diagnostics through thoughtful and educational dialogue.
In this inaugural episode of the ”Dialogues in CDx” podcast series, you’ll hear about the intricate relationship between diagnostic cutoffs and clinical data. In the PD-L1 space, there are multiple scoring algorithms, cutoffs, assays, and staining platforms for various indications, leading to frustration among pathologists. This episode centers on the question ”Why is the PD-L1 domain so complex?” To answer this, the origins of cutoffs and algorithms, and how they are applied to the right patients, are explored.
To discuss the topic, the host Scott W. Boyer is joined by two esteemed guests, one representing the perspective of the pathologist working in clinical practice, and the other representing the perspective of the industry that develops CDx assays. Dr. Hans-Ulrich Schildhaus is Executive Vice President of Pathology and Medical Affairs at Discovery Life Sciences Biomarker Services, as well as Medical Director and one of the Managing Directors of Pathology Nordhessen. Dr. Douglas Clark is the Chief Pathologist in the CDx Division at Agilent Technologies. He has expertise in pathology artificial intelligence, cytopathology, and molecular diagnostics.
This podcast series is part of the educational resources supporting the PD-L1 IHC 22C3 pharmDx assay.
For access to all episodes plus a wealth of additional PD-L1 education for pathologists, explore Agilent's CDx Digital Education Portaltoday.
D0130685_1.00
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.